Skip to contentI
Intelligent Bio Solutions Inc.
I
INBSIntelligent Bio Solutions Inc. Q1 2024 · 10-Q
Revenue$796.09K$796.09K+155.7% vs Q1 2023 Net Income-$2.43M-$2.43MN/M vs Q1 2023 EPS Diluted-$12.48-$12.48N/M vs Q1 2023 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
Operating Cash Flow-$1,311,833N/M Margins · derivedGross margin29.2%
Operating margin-317.3%+74.0 pt vs Q1 2023
Net margin-304.6%+83.5 pt vs Q1 2023
ended Sep 30, 2023 · filed Nov 8, 2023 · 39 d after period end